GENIUS GROUP LTD (GNS)

SGXZ34583559 - Common Stock

0.5762  -0.03 (-4.76%)

After market: 0.5748 0 (-0.24%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GNS. GNS was compared to 66 industry peers in the Diversified Consumer Services industry. Both the profitability and financial health of GNS have multiple concerns. GNS is valued quite expensively, but it does show have an excellent growth rating.



1

1. Profitability

1.1 Basic Checks

In the past year GNS has reported negative net income.
In the past year GNS has reported a negative cash flow from operations.
In the past 5 years GNS always reported negative net income.
GNS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

GNS's Return On Assets of -13.09% is on the low side compared to the rest of the industry. GNS is outperformed by 67.19% of its industry peers.
Looking at the Return On Equity, with a value of -40.33%, GNS is doing worse than 65.63% of the companies in the same industry.
Industry RankSector Rank
ROA -13.09%
ROE -40.33%
ROIC N/A
ROA(3y)-32.92%
ROA(5y)-24.83%
ROE(3y)-312.72%
ROE(5y)-200.62%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 51.76%, GNS is in line with its industry, outperforming 51.56% of the companies in the same industry.
GNS's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for GNS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.13%
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

GNS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GNS has more shares outstanding
The debt/assets ratio for GNS has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -3.21, we must say that GNS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.21, GNS is doing worse than 79.69% of the companies in the same industry.
GNS has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
GNS has a better Debt to Equity ratio (0.03) than 67.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -3.21
ROIC/WACCN/A
WACC7.82%

2.3 Liquidity

A Current Ratio of 0.56 indicates that GNS may have some problems paying its short term obligations.
The Current ratio of GNS (0.56) is worse than 81.25% of its industry peers.
GNS has a Quick Ratio of 0.56. This is a bad value and indicates that GNS is not financially healthy enough and could expect problems in meeting its short term obligations.
GNS has a Quick ratio of 0.51. This is amonst the worse of the industry: GNS underperforms 82.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.51

7

3. Growth

3.1 Past

GNS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 95.87%, which is quite impressive.
GNS shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.76%.
The Revenue has been growing by 44.56% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)95.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-637.26%
Revenue 1Y (TTM)26.76%
Revenue growth 3Y44.56%
Revenue growth 5YN/A
Sales Q2Q%-70.43%

3.2 Future

The Earnings Per Share is expected to grow by 40.24% on average over the next years. This is a very strong growth
Based on estimates for the next years, GNS will show a very strong growth in Revenue. The Revenue will grow by 21.90% on average per year.
EPS Next Y95.15%
EPS Next 2Y40.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.75%
Revenue Next 2Y21.9%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GNS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GNS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

GNS's earnings are expected to grow with 40.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.24%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for GNS!.
Industry RankSector Rank
Dividend Yield N/A

GENIUS GROUP LTD

NYSEARCA:GNS (11/4/2024, 8:12:30 PM)

After market: 0.5748 0 (-0.24%)

0.5762

-0.03 (-4.76%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.72M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.09%
ROE -40.33%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 51.76%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.56
Quick Ratio 0.51
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)95.87%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y95.15%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)26.76%
Revenue growth 3Y44.56%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y